The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Non-invasive Prenatal Testing Market By The End Of 2030?
The non-invasive prenatal testing market has experienced rapid growth in recent years. It is projected to expand from $6.27 billion in 2025 to $7.21 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.0%. Historically, this expansion has been fueled by factors such as increasing awareness of prenatal screening, reduced reliance on invasive diagnostic methods, the growing application of assay kits and reagents, the adoption of next-generation sequencing in laboratories, and the demand for early detection of chromosomal abnormalities.
The non-invasive prenatal testing market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $12.37 billion, demonstrating a compound annual growth rate (CAGR) of 14.4%. This forecasted growth is largely driven by several factors: the global increase in the adoption of non-invasive prenatal testing, greater investment in advanced sequencing technologies, the expansion of hospital and diagnostic laboratory networks, a rising need for early genetic screening, and the progressive integration of AI and data analytics into prenatal diagnostics. Key trends expected during this period involve the increasing adoption of AI-based genetic analysis, a greater utilization of NGS and PCR systems for prenatal testing, the expanding implementation of cloud-based data management within diagnostics, the broader deployment of high-throughput screening technologies, and the evolving integration of personalized prenatal risk assessment.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp
Which Market Drivers Are Supporting The Expansion Of The Non-invasive Prenatal Testing Market?
The expansion of the non-invasive prenatal testing market is anticipated to be fueled by the rising age of mothers. A variety of factors contribute to this trend of increasing maternal age, including the pursuit of education and career aspirations, the desire for financial security, personal preferences, later marriages, advancements in contraception, and broader societal shifts, all of which empower women to make more considered choices regarding family planning. With women choosing to postpone childbirth, the likelihood of chromosomal abnormalities increases, leading more pregnant individuals to select NIPT for evaluating the well-being of their unborn children. For example, in March 2025, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2023, the average age of mothers at their first birth reached 27.5 years, an increase from 27.4 in 2022, setting a new national peak. Consequently, the rising maternal age will persistently stimulate the development of the non-invasive prenatal testing market.
Which Segment Classifications Shape The Non-invasive Prenatal Testing Market?
The non-invasive prenatal testing market covered in this report is segmented –
1) By Type: Consumables, Instruments
2) By Application: Trisomy, Microdeletion, Genetics, Rh factor
3) By End User: Hospital, Diagnostic Labs
Subsegments:
1) By Consumables: Assay Kits, Reagents, Disposables
2) By Instruments: Next-Generation Sequencers (NGS), Polymerase Chain Reaction (PCR) Systems, Ultrasound Devices
What Key Trends Are Influencing The Development Of The Non-invasive Prenatal Testing Market?
Key companies operating in the non-invasive prenatal testing (NIPT) market are concentrating on developing advanced solutions, such as linked-SNP (single nucleotide polymorphism) technology, to enhance diagnostic precision, improve the detection of complex genetic cases, and reduce the reliance on paternal samples. This linked-SNP technology functions by evaluating single-gene variants through the analysis of genetically linked markers across the genome to infer inheritance patterns, thus enabling more accurate identification of challenging conditions like homozygous mutations. For example, in August 2025, Natera, a US-based company specializing in cell-free DNA (cfDNA) testing and precision medicine, introduced Fetal Focus. This NIPT is designed for inherited single-gene disorders, directly screening the fetus using only maternal blood when the biological father is unavailable. The test targets five genes: CFTR, SMN1, HBA1/HBA2, and HBB, and is supported by data from the EXPAND clinical trial. In its initial readout (n=101), Fetal Focus demonstrated 91% sensitivity and successfully detected all five homozygous variant fetuses, showcasing the strength of its linked-SNP–based approach in delivering noninvasive and clinically meaningful risk assessment.
Which Companies Are Expanding Their Footprint In The Non-invasive Prenatal Testing Market?
Major companies operating in the non-invasive prenatal testing market are F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health Plc, Ariosa Diagnostics Inc., Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc., Beijing Genomics Institute
Read the full non-invasive prenatal testing market report here:
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report
How Is The Non-invasive Prenatal Testing Market Distributed Across Key Geographic Regions?
North America was the largest region in the non-invasive prenatal testing market in 2025. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Non-invasive Prenatal Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2492&type=smp
Browse Through More Reports Similar to the Global Non-invasive Prenatal Testing Market 2026, By The Business Research Company
Non Injectable Insulin Global Market Report
https://www.thebusinessresearchcompany.com/report/non-injectable-insulin-global-market-report
Oem Insulation Global Market Report
https://www.thebusinessresearchcompany.com/report/oem-insulation-global-market-report
Antidiabetics Global Market Report
https://www.thebusinessresearchcompany.com/report/antidiabetics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model